ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980

Digital Immunoassay PSA Test May Predict Cancer Recurrence

October 28, 2011

Malpractice Reform Bill Introduced

July 28, 1989

New Funding Mechanisms – Cooperative Agreement, Consortium Grant – Proposed For Clinical Groups

April 6, 1979

Walter Reed Oncologic Pharmacy Residency Program Has Openings

November 25, 1988